Literature DB >> 18988905

Decreased damage from transient focal cerebral ischemia by transfusion of zero-link hemoglobin polymers in mouse.

Toshiaki Mito1, Masaaki Nemoto, Herman Kwansa, Kenji Sampei, Murtuza Habeeb, Stephanie J Murphy, Enrico Bucci, Raymond C Koehler.   

Abstract

BACKGROUND AND
PURPOSE: Transfusion of large polymers of hemoglobin avoids the peripheral extravasation and hypertension associated with crosslinked tetrameric hemoglobin transfusion and may be more effective in rescuing brain from focal ischemia. Effects of transfusion of high-oxygen-affinity hemoglobin polymers of different weight ranges were determined.
METHODS: Hypervolemic exchange transfusion was performed during 2 hours of middle cerebral artery occlusion in mice.
RESULTS: Compared to transfusion with a 5% albumin solution or no transfusion, infarct volume was reduced 40% by transfusion of a 6% solution containing hemoglobin polymers in the nominal range 500 to 14 000 kDa. Infarct volume was not significantly reduced by transfusion of a lower concentration of 2% to 3% of this size range of polymers, 6% hemoglobin solutions without removal of polymers <500 kDa or >14000 kDa, or crosslinked hemoglobin tetramers with normal oxygen affinity. Exchange transfusion with the 6% solution of the 500 to 14 000 kDa hemoglobin polymers did not improve the distribution of cerebral blood flow during focal ischemia and, in mice without ischemia, did not affect flow to brain or other major organs.
CONCLUSIONS: An intermediate size range of polymerized bovine hemoglobin possessing high oxygen affinity appears optimal for rescuing mouse brain from transient focal cerebral ischemia. A minimum concentration of a 6% solution is required, the rescue is superior to that obtained with crosslinked tetrameric hemoglobin possessing normal oxygen affinity, and tissue salvage is not associated with increased blood flow. This polymer solution avoids the adverse effects of severe renal and splanchnic vasoconstriction seen with crosslinked tetrameric hemoglobin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18988905      PMCID: PMC2612731          DOI: 10.1161/STROKEAHA.108.526731

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

Review 1.  Recommendations for standards regarding preclinical neuroprotective and restorative drug development.

Authors: 
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

2.  Vascular response to infusions of a nonextravasating hemoglobin polymer.

Authors:  Barbara Matheson; Herman E Kwansa; Enrico Bucci; Annette Rebel; Raymond C Koehler
Journal:  J Appl Physiol (1985)       Date:  2002-10

3.  A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2 transporter.

Authors:  Kevin M Bobofchak; Toshiaki Mito; Sarah J Texel; Andrea Bellelli; Masaaki Nemoto; Richard J Traystman; Raymond C Koehler; William S Brinigar; Clara Fronticelli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-10       Impact factor: 4.733

4.  The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable.

Authors:  Steven A Gould; Ernest E Moore; David B Hoyt; Paul M Ness; Edward J Norris; Jeffrey L Carson; George A Hides; Ian H G Freeman; Richard DeWoskin; Gerald S Moss
Journal:  J Am Coll Surg       Date:  2002-10       Impact factor: 6.113

5.  Characterization of a new double-filament model of focal cerebral ischemia in heme oxygenase-2-deficient mice.

Authors:  Shozo Goto; Kenji Sampei; Nabil J Alkayed; Sylvain Doré; Raymond C Koehler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-03-27       Impact factor: 3.619

6.  Regional cerebral blood flow in cats with cross-linked hemoglobin transfusion during focal cerebral ischemia.

Authors:  Annette Rebel; John A Ulatowski; Karena Joung; Enrico Bucci; Richard J Traystman; Raymond C Koehler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

7.  Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery.

Authors:  Akira T Kawaguchi; Dai Fukumoto; Munetaka Haida; Yoshitaka Ogata; Mariko Yamano; Hideo Tsukada
Journal:  Stroke       Date:  2007-03-29       Impact factor: 7.914

8.  Cerebrovascular response to decreased hematocrit: effect of cell-free hemoglobin, plasma viscosity, and CO2.

Authors:  Annette Rebel; John A Ulatowski; Herman Kwansa; Enrico Bucci; Raymond C Koehler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06-19       Impact factor: 4.733

9.  Calculations of oxygen transport by red blood cells and hemoglobin solutions in capillaries.

Authors:  Arjun Vadapalli; Daniel Goldman; Aleksander S Popel
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2002-05

10.  Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics.

Authors:  Amy G Tsai; Kim D Vandegriff; Marcos Intaglietta; Robert M Winslow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06-12       Impact factor: 4.733

View more
  12 in total

Review 1.  Pre-clinical studies using OxyVita hemoglobin, a zero-linked polymeric hemoglobin: a review.

Authors:  John P Harrington; Hanna Wollocko
Journal:  J Artif Organs       Date:  2010-12-03       Impact factor: 1.731

2.  Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion.

Authors:  Judith A Klaus; Kathleen K Kibler; Abraham Abuchowski; Raymond C Koehler
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2010-10

3.  Contributions of poly(ADP-ribose) polymerase-1 and -2 to nuclear translocation of apoptosis-inducing factor and injury from focal cerebral ischemia.

Authors:  Xiaoling Li; Judith A Klaus; Jian Zhang; Zhenfeng Xu; Kathleen K Kibler; Shaida A Andrabi; Karthik Rao; Zeng-Jin Yang; Ted M Dawson; Valina L Dawson; Raymond C Koehler
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

4.  Gastric antisecretory and antiulcer activity of bovine hemoglobin.

Authors:  Abdulrahman K Al Asmari; Saud Al Omani; Ibrahim Elfaki; Mohammad Tariq; Ahmed Al Malki; Saeed Al Asmary
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

5.  Transfusion of hemoglobin-based oxygen carriers in the carboxy state is beneficial during transient focal cerebral ischemia.

Authors:  Jian Zhang; Suyi Cao; Herman Kwansa; Daina Crafa; Kathleen K Kibler; Raymond C Koehler
Journal:  J Appl Physiol (1985)       Date:  2012-10-04

6.  Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion.

Authors:  Suyi Cao; Liang-Chao Wang; Herman Kwansa; Richard J Roman; David R Harder; Raymond C Koehler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-04       Impact factor: 3.619

7.  Molecular Design Properties of OxyVita Hemoglobin, a New Generation Therapeutic Oxygen Carrier: A Review.

Authors:  John P Harrington; Hanna Wollocko
Journal:  J Funct Biomater       Date:  2011-12-16

8.  Effects of the Oxygen-Carrying Solution OxyVita C on the Cerebral Microcirculation and Systemic Blood Pressures in Healthy Rats.

Authors:  Rania Abutarboush; Chioma Aligbe; Georgina Pappas; Biswajit Saha; Francoise Arnaud; Ashraful Haque; Charles Auker; Richard McCarron; Anke Scultetus; Paula Moon-Massat
Journal:  J Funct Biomater       Date:  2014-11-18

Review 9.  Anemia and red blood cell transfusion in neurocritical care.

Authors:  Andreas H Kramer; David A Zygun
Journal:  Crit Care       Date:  2009-06-11       Impact factor: 9.097

10.  Using a novel in vivo model to study the function of nuclear factor kappa B in cerebral ischemic injury.

Authors:  Rui Wang; Songlan Liang; Hui Yue; Lijie Chen
Journal:  Med Sci Monit       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.